Amphastar Pharmaceuticals (AMPH) Cash from Operations (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Cash from Operations of 47840000.0 for Q1 2026, up 36.39% year-over-year from 35077000.0 in Q1 2025, and up 45.57% quarter-over-quarter from 32863000.0 in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Cash from Operations (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Cash from Operations history runs 14 years deep, the most recent figure standing at 47840000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 36.39% year-over-year to 47840000.0; the TTM figure through Mar 2026 stood at 168878000.0 (down 12.58% YoY), while the FY2025 annual figure was 156115000.0, down 26.84% from the prior year.
- Cash from Operations for Q1 2026 stood at 47840000.0, up from 32863000.0 in the prior quarter.
- The five-year high for Cash from Operations was 69109000.0 in Q2 2024, with the low at 2815000.0 in Q2 2022.
- The 5-year median for Cash from Operations is 40382000.0 (2023), against an average of 40589705.88.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations slumped 91.25% in 2022, then surged 1851.08% in 2023.
- Amphastar Pharmaceuticals' Cash from Operations stood at 15226000.0 in 2022, then soared by 56.73% to 23864000.0 in 2023, then rose by 21.62% to 29024000.0 in 2024, then gained by 13.23% to 32863000.0 in 2025, then surged by 45.57% to 47840000.0 in 2026.
- Business Quant data shows AMPH's Cash from Operations at 47840000.0 in Q1 2026, 32863000.0 in Q4 2025, and 52583000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 943.15 Mn | 653.02 Mn | 93.47 Mn | 51.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.32 Mn |
| Jun 30, 2026 | 51.32 Mn |
| Mar 31, 2026 | 47.84 Mn |
| Mar 31, 2026 | 47.84 Mn |
| Dec 31, 2025 | 32.86 Mn |
| Dec 31, 2025 | 32.86 Mn |
| Sep 30, 2025 | 52.58 Mn |
| Sep 30, 2025 | 52.58 Mn |
| Jun 30, 2025 | 35.59 Mn |
| Jun 30, 2025 | 35.59 Mn |
| Mar 31, 2025 | 35.08 Mn |
| Mar 31, 2025 | 35.08 Mn |
| Dec 31, 2024 | 29.02 Mn |
| Dec 31, 2024 | 29.02 Mn |
| Sep 30, 2024 | 59.96 Mn |
| Sep 30, 2024 | 59.96 Mn |
| Jun 30, 2024 | 69.11 Mn |
| Jun 30, 2024 | 69.11 Mn |
| Mar 31, 2024 | 55.29 Mn |
| Mar 31, 2024 | 55.29 Mn |